Overview

Quality of Recovery After Reversal With Neostigmine or Sugammadex.

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This study will compare patient recovery measures after reversal of neuromuscular blockade with neostigmine or sugammadex after surgery. Measures include pulmonary function, muscle strength, time to extubation and quality of recovery in the post anesthesia care unit.
Phase:
Phase 4
Details
Lead Sponsor:
Stony Brook University
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Neostigmine